Peritoneal Dialysis vs Hemodialysis: Key Differences and Clinical Selection
Both peritoneal dialysis (PD) and hemodialysis (HD) provide similar long-term survival outcomes in patients eligible for both modalities, but PD offers greater patient autonomy, lower costs, and may provide a survival advantage in the first 1.5-2 years of dialysis, particularly in younger patients and those with residual kidney function. 1, 2, 3
Fundamental Mechanistic Differences
Peritoneal Dialysis
- Uses the peritoneum as a natural semipermeable membrane with blood flow from peritoneal microcirculation, eliminating the need for an extracorporeal circuit 4
- Removes solutes through diffusion (primary mechanism for small molecules) and convection (solvent drag during ultrafiltration) 4
- Achieves only 10-20% of normal kidney clearance for urea and creatinine, with even lower clearance for higher molecular weight solutes 4
- Continuous 24-hour treatment maximizes middle molecule clearance 4
Hemodialysis
- Requires vascular access and extracorporeal blood circuit with artificial membrane 1
- Typically performed 3 times weekly in-center, though home HD options exist 1
- Provides intermittent but more intensive solute clearance per session 1
Survival Outcomes: The Critical Timeline
The survival advantage of PD is time-dependent and changes predictably over the dialysis course. 2, 5
- First 3 months: PD shows lower mortality risk compared to in-center HD 2
- First 1.5-2 years: PD survival advantage continues, especially in non-diabetic and younger diabetic patients 2, 5
- Beyond 2 years: Mortality risk with PD equals or exceeds HD, depending on patient factors 2
- Among patients eligible for both modalities: No significant survival difference at any time point 3
Critical caveat: The apparent early PD survival advantage in population studies may reflect selection bias rather than true modality effect, as healthier patients often choose PD 6, 3
Advantages of Peritoneal Dialysis
Patient-Centered Benefits
- Greater autonomy and treatment satisfaction compared to in-center HD 1
- Home-based therapy allows flexibility in scheduling and lifestyle 1, 7
- Preservation of residual kidney function longer than HD 7
- Lower treatment costs to healthcare system 1, 2, 7
Clinical Benefits
- Better preservation of residual renal function, particularly important early in dialysis 7
- Continuous solute and fluid removal provides more stable hemodynamics 4
- No need for vascular access, avoiding catheter-related bloodstream infections 2
Disadvantages of Peritoneal Dialysis
Infection Risks
- Peritonitis remains the primary complication, with unacceptably frequent episodes requiring modality switch 1
- Diverticulitis during PD often results in peritonitis 1
- Abdominal or chest wall infections can contaminate catheter exit site and peritoneal cavity 8
Nutritional Concerns
- Continuous protein loss through peritoneum can contribute to malnutrition 1, 4
- Excessive protein losses occur in high transporters, active nephrosis, or frequent peritonitis 1
- Increased caloric absorption from glucose-based dialysate may worsen obesity 1
Technical Limitations
- High technique failure rate persists despite reduced peritonitis rates 2
- Inadequate ultrafiltration in high transporters may require burdensome short-dwell regimens 1
- Low transporters in large patients may have inadequate peritoneal clearance 1
- Mechanical problems (catheter malposition, hernias, leaks) can necessitate modality switch 1
Metabolic Issues
- Unmanageably severe hypertriglyceridemia from dextrose load may increase cardiovascular risk 1
Advantages of Hemodialysis
- More efficient solute clearance per treatment session 1
- No continuous protein losses 4
- Suitable for patients with peritoneal membrane failure or extensive abdominal adhesions 8
- Direct supervision by healthcare professionals during treatment 1
- Better option for patients unable to perform self-care or lacking suitable care-partner 8
Disadvantages of Hemodialysis
- Vascular access complications, particularly catheter-related bloodstream infections 2
- Requires travel to dialysis center 3 times weekly (for in-center HD) 1
- Less patient autonomy and lifestyle flexibility 1
- Intermittent treatment causes hemodynamic instability in some patients 4
- Higher costs to healthcare system 1, 2, 7
- Faster loss of residual kidney function 7
Absolute Contraindications to Peritoneal Dialysis
PD should not be offered when: 8
- Documented loss of peritoneal function or extensive abdominal adhesions limiting dialysate flow 8
- Patient physically or mentally unable to perform PD without suitable assistant 8
- Uncorrectable mechanical defects (irreparable hernias, omphalocele, gastroschisis, diaphragmatic hernia, bladder exstrophy) 8
Relative Contraindications to Peritoneal Dialysis
Consider HD instead when: 1, 8
- Recent intra-abdominal foreign bodies (require 4-month waiting period after vascular prostheses or ventriculoperitoneal shunt) 8
- Morbid obesity creating catheter placement problems or risk of further weight gain 1, 8
- Severe malnutrition with compromised wound healing 1, 8
- Frequent diverticulitis episodes 1, 8
- Inflammatory or ischemic bowel disease 8
- Body size extremes (too small for prescribed volumes or too large for adequate dialysis) 8
Mandatory Indications for Switching from PD to HD
Transfer from PD to HD is required when: 1
- Consistent failure to achieve target Kt/Vurea and creatinine clearance despite optimal prescription 1
- Inadequate ultrafiltration or solute transport unresponsive to prescription adjustments 1
- Unacceptably frequent peritonitis or PD-related complications 1
- Irreparable technical/mechanical catheter problems 1
- Severe malnutrition resistant to aggressive management 1
- Unmanageably severe hypertriglyceridemia 1
Clinical Decision Algorithm
For incident dialysis patients with residual kidney function and no contraindications:
- Start with PD to maximize early survival advantage, preserve residual function, and provide lifestyle flexibility 2, 5, 7
- Plan for "healthy start" integrated care approach with timely transfer to HD when complications arise 5
For elderly or frail patients:
- Consider PD with home nursing support to enable home-based therapy 7
- Evaluate care-partner availability and patient's physical/cognitive ability 8
For patients with severe comorbidities or limited life expectancy:
- Either modality appropriate based on patient preference, as survival outcomes are similar 3
- Prioritize quality of life and treatment satisfaction in decision-making 1
For patients with contraindications to PD:
- HD is the appropriate choice when absolute contraindications exist 8
- Relative contraindications require individualized risk-benefit assessment 8
Common Pitfalls to Avoid
- Failing to provide high-quality pre-dialysis education about both modalities leads to physician bias determining modality rather than informed patient choice 1, 2
- Keeping patients on failing PD too long when clear indications for HD transfer exist increases morbidity and mortality 1
- Assuming PD survival advantage persists indefinitely when evidence shows it diminishes after 1.5-2 years 2
- Not planning vascular access early in PD patients who will eventually need HD 1
- Ignoring protein losses and malnutrition in PD patients, which increases mortality risk 1, 4